Treatment primarily involves supportive care, which may include mechanical ventilation for respiratory support. The use of Botulism Immune Globulin Intravenous (BIG-IV) has been shown to reduce the duration of hospitalization and improve outcomes. Antibiotics are generally not recommended as they can exacerbate the release of the toxin.
